You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Chloride 0.9% And Potassium Chloride 0.075% In Plastic Container, and when can generic versions of Sodium Chloride 0.9% And Potassium Chloride 0.075% In Plastic Container launch?

Sodium Chloride 0.9% And Potassium Chloride 0.075% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER?
  • What are the global sales for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER?
Summary for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
Drug patent expirations by year for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER

US Patents and Regulatory Information for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-001 Nov 9, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Sodium Chloride 0.9% and Potassium Chloride 0.075% in Plastic Containers

Introduction

Sodium chloride 0.9% and potassium chloride 0.075% solutions, often used in medical settings for fluid and electrolyte replenishment, are integral components of healthcare. This article delves into the market dynamics and financial trajectory of these solutions, particularly when packaged in plastic containers.

Market Overview

The global market for intravenous solutions, including sodium chloride and potassium chloride, is driven by several key factors.

Growing Demand in Healthcare

The increasing need for fluid and electrolyte replenishment in hospitals and clinics is a significant driver. As the global population ages and healthcare needs rise, the demand for these solutions is expected to grow steadily[3].

Application in Various Industries

Apart from healthcare, these solutions are used in various industries such as agriculture (as fertilizers), food processing, and pharmaceuticals. However, the focus here remains on their medical applications.

Market Size and Forecast

Current Market Size

As of 2022, the global potassium chloride market, which includes medical applications, was valued at approximately USD 13.08 billion[3].

Projected Growth

The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.3% from 2023 to 2033, reaching a valuation of around USD 18,102.7 million by 2033[1].

Key Drivers of Market Growth

Increasing Use in Medical Settings

Sodium chloride 0.9% and potassium chloride 0.075% solutions are crucial for maintaining fluid balance and electrolyte levels in patients. The rising incidence of diseases and the need for intravenous therapies drive the demand for these solutions[2].

Technological Advancements

Advancements in packaging technology, such as the use of flexible plastic containers (e.g., VIAFLEX Plus), have improved the safety and efficiency of these solutions. These containers reduce the risk of air embolism and ensure the stability of the solution[2].

Regulatory Compliance

Compliance with regulatory standards, such as those set by the USP (United States Pharmacopeia), is essential for the market growth. Manufacturers must ensure their products meet these standards to maintain market presence[2].

Market Dynamics

Competitive Landscape

The market for intravenous solutions is moderately consolidated, with key players holding a significant share. However, there is an expectation of fragmentation as emerging players enter the market. Key players are likely to engage in production facility expansions and acquisitions to maintain their market share[1].

Regional Market Focus

The United States and China are prominent markets for potassium chloride solutions. The United States holds a significant share in the North American market, driven by its extensive use in agriculture and healthcare. China's industrial expansion, particularly in water treatment, food processing, and agriculture, also fuels the demand for potassium chloride[1].

Challenges and Restraints

Toxic Nature and Safety Concerns

Potassium chloride can be toxic if not administered correctly, particularly in patients with severe renal impairment. This necessitates careful administration and monitoring, which can be a restraint in market growth[3].

Raw Material Pricing

Fluctuations in the prices of raw materials can impact the production costs and profitability of manufacturers. This volatility can hinder market growth and stability[5].

Financial Trajectory

Revenue Growth

The revenue growth of the potassium chloride market, including medical applications, is expected to be steady. With a CAGR of 3.3%, the market is projected to expand significantly over the next decade[1].

Investment and Expansion

Key players are expected to invest in production facility expansions and acquisitions to capitalize on the growing demand. This investment will be crucial in meeting the increasing needs of the healthcare sector[1].

Distribution and Supply Chain

Supply Availability

The supply chain for these solutions is critical, especially in healthcare settings where timely availability is essential. Reports indicate that distributors and wholesalers play a vital role in ensuring the supply of these solutions, often managing demand through allocation systems[4].

End-Use Verticals

Medical and Pharmaceutical

The primary end-use vertical for sodium chloride 0.9% and potassium chloride 0.075% solutions is the medical and pharmaceutical sector. These solutions are used for fluid and electrolyte replenishment, making them indispensable in hospitals and clinics[2].

Other Industries

While the focus is on medical applications, these solutions also find use in other industries such as agriculture and food processing. However, the medical sector remains the most significant driver of demand[1].

Key Takeaways

  • The global market for potassium chloride solutions, including medical applications, is projected to grow at a CAGR of 3.3% from 2023 to 2033.
  • The United States and China are key markets driven by their significant healthcare and industrial sectors.
  • Technological advancements in packaging and regulatory compliance are crucial for market growth.
  • Challenges include the toxic nature of potassium chloride and fluctuations in raw material prices.
  • The medical and pharmaceutical sector is the primary end-use vertical for these solutions.

FAQs

Q: What is the projected market size for potassium chloride by 2033?

The global potassium chloride market is expected to reach a valuation of approximately USD 18,102.7 million by 2033[1].

Q: What are the primary drivers of the potassium chloride market?

The primary drivers include increasing demand in healthcare, technological advancements in packaging, and regulatory compliance[1][3].

Q: Which regions are expected to dominate the potassium chloride market?

The United States and China are expected to remain prominent in the market due to their significant healthcare and industrial sectors[1].

Q: What are the potential restraints in the potassium chloride market?

Potential restraints include the toxic nature of potassium chloride and fluctuations in raw material prices[3][5].

Q: How does the supply chain impact the market for sodium chloride 0.9% and potassium chloride 0.075% solutions?

The supply chain is critical, with distributors and wholesalers managing demand through allocation systems to ensure timely availability in healthcare settings[4].

Sources

  1. Future Market Insights: Potassium Chloride Market Size, Growth, Trend & Share | 2033
  2. Baxter Corporation: Potassium Chloride in 0.9% Sodium Chloride Injection, USP
  3. Emergen Research: Potassium Chloride Market Size, Trend, Demand Analysis Till 2032
  4. Baxter Corporation: USHP Supply Availability Report - November 7th 2023
  5. Maximize Market Research: Potassium Chloride Market - Global Analysis and Forecast

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.